alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit
32**
 
 CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2003 (Section 1350 of Chapter 63 of
Title 18 of the United States Code), each of the undersigned officers of Severn
Bancorp, Inc. (the “Company”) does hereby certify with respect to the Annual
Report of the Company on Form 10-K for the period ended December 31, 2004
(the “Report”) that:
 
 (1)  This
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 (2)  The
information contained in this Report fairly presents, in all material respects,
the financial condition and result of operations of the Registrant.
 
 SEVERN BANCORP,
INC.
 
 
 Date:
March 15, 2005 /s/
Alan J. Hyatt
 Alan J.
Hyatt, President, Chief Executive Officer
 and
Chairman of the Board
 (Principal
Executive Officer)
 
 
 Date:
March 15, 2005 /s/
Cecelia Lowman
 Cecelia
Lowman, Chief Financial Officer
 (Principal
Financial and Accounting Officer)
Amendment to Consulting Agreement



 Exhibit 10.42 
 AMENDMENT TO CONSULTING AGREEMENT 
 This Amendment to Consulting Agreement (“Amendment”) is
made and entered into by and between SCOLR Pharma, Inc., a Delaware corporation, formerly known as Nutraceutix, Inc., and Dr. Reza Fassihi (“Dr. Fassihi”). Effective as of December 31, 2006, the Consulting Agreement dated as of
December 22, 2000 (the “Consulting Agreement”), and the Additional Services Agreement (the “additional Services Agreement”) effective as of August 7, 2002, between SCOLR and Dr. Fassihi, are hereby amended as
follows: 
  

	 	1.	Paragraph 1 of the Consulting Agreement is hereby amended to provide that the Term shall continue until terminated in accordance with paragraph 14 of the Consulting Agreement.


  

	 	2.	The second sentence of Paragraph 2 of the Consulting Agreement shall be replaced with the following: “During the Term, Dr. Fassihi shall provide such additional Services
as may be mutually agreed upon by the parties from time to time. 

  

	 	3.	Except as specifically set forth in this Agreement, the Consulting Agreement and the Additional Services Agreement shall remain in full force and effect. 


IN WITNESS WHEREOF, the parties have executed this Agreement as of this 18th day of January 2007: 
  

									
	SCOLR Pharma, Inc.	 		 	Dr. Fassihi
					
	By:	 	 /s/ Daniel O. Wilds
	 		 	By:	 	 /s/ Reza Fassihi

		 	 Daniel O. Wilds
 President & CEO
	 		 		 	Dr. Reza Fassihi
					
	 Address:
	 	 3625 132nd Ave.
SE, Suite 400
 Bellevue, WA 98006
	 		 	Address:	 	 352 Dreshertown Road
 Fort Washington, PA
19034

			
	Date Signed: Jan. 18, 2007	 		 	Date Signed: Jan. 11, 2007
|  |
|--|

FDA Home Page |NCTR Home |NCTR Initiatives | NCTR Science |NCTR Site Map

| -  Fiscal year 2003-2004 
-  Fiscal year 2002-2003 
-   Fiscal Year 2001-2002 
-  Fiscal Year 2000-2001 
-   Fiscal Year 1999-2000 
-  Fiscal Year 1998-1999 
-   Fiscal Year 1997-1998 
-  Fiscal Year 1996-1997 

Some of the documents on this section of the NCTR Website are availableonly in PDF format and may not be accessible to those with certain disabilities.  Ifyou cannot access the documents you are interested in, please e-mail webmaster@nctr.fda.gov for assistance. |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

# 

Contact NCTRFDA Home Page |Search   FDA Site |A-Z Index |Contact FDA |Privacy |Accessibility

FDA/National Center for Toxicological ResearchWeb page updated by rla2004-APR-09.
**Exhibit 23.1**
**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Nos.333-11685, 33-88135, 333-49298, 333-106422, 333-110245, 333-112011, 333-113629, and 333-116548) and Form S-3 (No. 333-108343) of Electronics for Imaging, Inc. ofour report dated March 15, 2004, relating to the financial statements, financial statementschedule, management’s assessment of the effectiveness of internal control over financial reporting andthe effectiveness of internal control over financial reporting, which appears in this Form 10-K.
**PricewaterhouseCoopers LLP**
San Jose, California
## In the Court of Appeals Second Appellate District of Texas

at Fort Worth

No. 02

- 23

- 00221

- CV

2016 P ARKVIEW C ONDOMINIUMS

D EVELOPMENT

, LLC

, Appellant and Appellee

V

.

L

AWRENCE E. M ARSHALL , Appellee and Appellant §

§

§

§ On Appeal fro m the 153rd District

Court

of Tarrant County ( 153

- 338058

- 22 )

February 22, 2024

Memorandum Opinion by Justice

Bassel

JUDGMENT

This court has considered the record on appeal in this case and holds that there

was no error in the trial court’s order

. It is ordered that the order of the trial court is

affirmed.

It is further ordered that 2016 Parkview Condominiums Development, LLC

and Lawrence E. Marshall shall split all costs of this appeal, for which let execution

issue.

SECOND DISTRICT COURT OF APPEALS

By /s/ Dabney Bassel Justice Dabney Bassel
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED August 8, 2005 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 04-41565 Summary Calendar

UNITED STATES OF AMERICA Plaintiff - Appellee

v. ROBERT H CLARK, JR Defendant - Appellant

-------------------- Appeal from the United States District Court for the Eastern District of Texas USDC No. 1:03-CR-232-1

-------------------- Before KING, Chief Judge, and SMITH and GARZA, Circuit Judges. PER CURIAM: * Robert H. Clark, Jr., appeals his sentence following his guilty plea conviction for conspiracy to possess with intent to distribute 500 grams or more of a mixture or substance containing methamphetamine, in violation of 18 U.S.C. §§ 841(a)(1), 846. Clark argues that his sentence must be vacated in light of United States v. Booker , 125 S. Ct. 738 (2005). In Booker , 125 S. Ct. at 756, the Supreme Court held that "[a]ny fact (other than a prior conviction) which is necessary toNo. 04-41565 -2- support a sentence exceeding the maximum authorized by the facts established by a plea of guilty or a jury verdict must be admitted by the defendant or proved to a jury beyond a reasonable doubt." Booker also struck down 18 U.S.C. § 3553(b)(1) and thus rendered the Guidelines advisory only. Id. at 764-65. The district court based Clark’s sentence on its finding that Clark was responsible for more than 1.5 kilograms of “ice,” which is a mixture or substance containing d-methamphetamine hydrochloride of at least 80 percent purity, and it calculated his offense level accordingly. The district court also applied a sentencing enhancement because a firearm was possessed in relation to this offense and for Clark’s role as a leader or organizer. Clark did not admit these facts in the district court and objected to the enhancements on Sixth Amendment grounds. Clark’s 360-month sentence exceeded the maximum sentence that could have been imposed based solely on his plea and constituted a Sixth Amendment violation under Booker
. See Booker , 125 S. Ct. at 769. When, as here, the defendant has preserved this error, we will ordinarily vacate the sentence and remand, unless we can say that the error is harmless. United States v. Pineiro , 410 F.3d. 282, 284 (5th Cir. 2005). In order to carry this burden, the Government must show that the Booker error did not affect the sentence that the defendant received; it must show “that theNo. 04-41565 -3- district court would have imposed the same sentence absent the error.” Id. at 286. Although the Government asserts that the sentence was reasonable, it concedes that it cannot establish beyond a reasonable doubt that the mandatory nature of the Sentencing Guidelines at the time of Clark’s sentence did not contribute to the sentence that he received. See id. Accordingly, Clark’s sentence must be vacated and remanded for resentencing. VACATED AND REMANDED.
Case 16-25652 Doc 13 Filed 08/15/16 Entered 08/16/16 09:36:53 Desc Main

 Document Page 1 of 1
**EXHIBIT
        32.1**
 
 **CERTIFICATION
        PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED**
 **PURSUANT
        TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**
  In
        connection
        with the Quarterly Report of Interactive Intelligence, Inc. (the “Registrant”)
        on Form 10-Q for the quarterly period ending September 30, 2007 as filed
        with
        the Securities and Exchange Commission on the date hereof (the “Report”),
        I,  Donald E. Brown, M.D., Chairman of the Board, President and Chief
        Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section
        1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
        that
        to the best of my knowledge:
 
 (1)
              The
                  Report, to which this certification is attached as Exhibit 32.1,
                  fully complies with the  requirements  of section 13(a) or
                  15(d) of the Securities Exchange Act of 1934;
                  and
 
 (2)
              The information contained in
                  the Report fairly presents, in all material respects,
                  the financial condition and results of operations of the
                  Registrant.
 
 
 /s/
        Donald E. Brown, M.D.
 Donald
        E.
        Brown, M.D.
 President
        and Chief Executive Officer
 (Principal
        Executive Officer)
 November
        2, 2007
#### § 218.61 Effective dates.

Regulations in this subpart are effective from April 13, 2023, through April 13, 2030.
2024 U.S. ElectionSeptember 23, 2024Returning Your Absentee Ballot from Overseas

Skip to main content

            - Home |
            - Travel Advisories  |
            - Newsroom |
            - About Us|
            - Contact Us  |
            - Careers |
            -  MyTravelGov |
            -  Find U.S. Embassies & Consulates 

### Travel.State.Gov

                  - Travel.State.Gov
                  -  Congressional Liaison
                  -  Special Issuance Agency
                  - U.S. Passports
                  - International Travel
                  - U.S. Visas
                  - Intercountry Adoption
                  - International Parental Child Abduction
                  - Records and Authentications

### Popular Links

                  - Home
                  - Travel Advisories
                  -  Newsroom  About Us  Contact Us  Careers   MyTravelGov  Find U.S. Embassies & Consulates    Stay Connected- 
- 
- 
- 
- 
- 
   Legal Resources- Legal Information
- Info for U.S. Law Enforcement
        Travel.State.GovU.S. DEPARTMENT of STATE — BUREAU of CONSULAR AFFAIRS** Travel.State.Gov  > International Travel > Learn About Your Destination > Bhutan International Travel Information-   Congressional Liaison 
-   Special Issuance Agency 
-  Legal Resources 
-  U.S. Passports 
-  International Travel 
-  U.S. Visas 
-  Intercountry Adoption 
-  International Parental Child Abduction 
-  Replace or Certify Documents 
International TravelEnglish-  Before You Go 
-  Learn About Your Destination 
-  While Abroad 
-  Emergencies 
Learn About Your Destination Travel.State.Gov  > International Travel > Learn About Your Destination > Bhutan International Travel Information
**Share this page:**
-  ** 
-  ** 
-  ** 
-  ** 
Bhutan  Bhutan Kingdom of BhutanTravel AdvisoryJune 26, 2024Bhutan - Level 1: Exercise Normal PrecautionsODKENHUTCExercise normal precautions in Bhutan.
***Reissued after periodic review without changes.***

Exercise normal precautions in Bhutan.

Read the country information page for additional information on travel to Bhutan.

If you decide to travel to Bhutan:
- Enroll in the  Smart Traveler Enrollment Program  ( STEP ) to receive Alerts and make it easier to locate you in an emergency.
- Follow the Department of State on  Facebook  and  Twitter .
- Review the  Country Security Report  for Bhutan.
- Visit the CDC page for the latest  Travel Health Information  related to your travel.
- Prepare a contingency plan for emergency situations. Review the  Traveler’s Checklist .
... [READ MORE]
#### § 20.32 During closed season.

No person shall possess any freshly killed migratory game birds during the closed season.
<PAGE>

                               EXHIBIT 10.16


Schedule identifying certain material details of documents substantially
identical to those set forth in exhibits 10.17, 10.18, 10.19 and 10.20

<TABLE>
<CAPTION>
                                           Promissory           Shares
                                           Note                 Underlying
By and between the         Agreement       Principal            Stock Purchase  Amendment       Amendment
Company and                Date            Amount               Warrant         Date            Date
---------------------------------------------------------------------------------------------------------
<S>                        <C>             <C>                  <C>             <C>             <C>
Wayne W. Mills             1-13-97         $125,000             25,000          3-4-97          6-5-97

James Sippl                1-17-97         $50,000              10,000          3-4-97          6-5-97

James Sippl                2-10-97         $100,000             20,000          3-4-97          6-5-97

Hayden R. Fleming
and Ladonna M.
Fleming irrevocable
Trust                      3-18-97         $50,000              10,000          N/A            
---------------------------------------------------------------------------------------------------------
Wyncrest Capital, Inc.     3-20-97         $125,000             25,000          N/A             6-5-97
</TABLE>
EXHIBIT 31.1  CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002   I, Michael Zwebner, the Chief Executive Officer of Reddi Brake Supply Corporation (the ACompany@), certify that:  1. I have reviewed this annual report on Form 10-KSB of the Company;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4.  I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have:  a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this report (the "Evaluation Date"); and  c) presented in this report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;  5. I have disclosed, based on my most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and   Date: August 8, 2007 By: /s/ Michael Zwebner Michael Zwebner Chief Executive Officer
§ 17.7 Raptor exemption. ( a ) The prohibitions found in §§ 17.21 and 17.31 do not apply to any raptor [a live migratory bird of the Order *Falconiformes* or the Order *Strigiformes,* other than a bald eagle (*Haliaeetus leucocephalus*) or a golden eagle (*Aquila chrysaetos*)] legally held in captivity or in a controlled environment on November 10, 1978, or to any of its progeny, which is: ( 1 ) Possessed and banded in compliance with the terms of a valid permit issued under part 21 of this chapter; and
( 2 ) Identified in the earliest applicable annual report required to be filed by a permittee under part 21 of this chapter as in a permittee's possession on November 10, 1978, or as the progeny of such a raptor.
( b ) This section does not apply to any raptor intentionally returned to the wild.
[48 FR 31607, July 8, 1983]
```

                                                                      Exhibit 3

                   NAVISTAR FINANCIAL SECURITIES CORPORATION
                     ARTICLES OF INCORPORATION AND BY-LAWS

The  following  documents  of Navistar  Financial  Securities  Corporation  are
incorporated herein by reference:

3.1   Certificate   of   Incorporation   of   Navistar   Financial   Securities
      Corporation (as in effect on   September 13, 1990).  Filed on
      Registration  No. 33-36767.

3.2   The  By-Laws  of  Navistar  Financial  Securities  Corporation.  Filed on
      Registration No. 33-36767.
```
<PAGE>   1
                                                                   EXHIBIT 10.55

                              [NEODATA LETTERHEAD]

February 27, 1997

Nancy Talmey

Dear Nancy:

To confirm your recent conversation with Larry Jones, we have revised our
agreement on severance with you. Our agreement is as follows:

-        In the event your employment is terminated for any of the reasons set
         forth in Neodata's Severance Policy, you will be paid a minimum of six
         (6) months of salary continuation payable bi-weekly and calculated
         based upon your annual base salary in effect at that time less any
         taxes to be withheld as required by law. If you do not find suitable
         alternative employment within that six (6) month period, severance
         payments will continue for an additional period equal to the lesser of
         six (6) months or until suitable alternative employment commences.

-        In exchange for the above consideration, you agree to not compete with
         the Company in any fashion for six (6) months following your
         termination from the Company without our written approval. Should we
         eventually sever you, we will provide you with an agreement which will
         specify more fully the noncompete and confidentiality arrangements.

         Please indicate your acceptance of this offer by signing and returning
         a copy of this letter to my attention by March 6, 1997.

Sincerely,


/s/ SUSAN L. MORSE

Susan L. Morse
Senior Vice President
Human Resources

AGREED AND ACCEPTED

/s/ NANCY TALMEY                                       2-28-97
------------------------                           -----------------
Nancy Talmey                                       Date

cc:
A. Laurence Jones





                                       18
September 17, 2015

Mr. Steven Parker

44 Brandy Lane

Wappingers Falls, NY 12590

Dear Mr. Parker:

This letter is to inform you that we are unable to process your petition for an exemption from 

Title 14, Code of Federal Regulations (14 CFR). It explains why we cannot process your 

request and what you should do in the next 30 days.

Why We Cannot Process Your Request

We received your exemption request filed in Docket No. FAA−2015−2759 on July 7, 2015, 

but we are unable to process your request any further. Your petition does not comply with the 

requirements of § 11.81 (copy enclosed). For us to consider the request any further, you must 

send us all of the following:

 The specific section or sections of 14 CFR from which you seek relief, the extent of the 

relief you seek, and the reason you seek relief.

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole.

 The reasons why the exemption would not adversely affect safety or how the exemption 

would provide a level of safety at least equal to that provided by the rule from which you 

seek an exemption.

 Any additional information, views, or arguments available to support your request.

For more detailed information relating to submitting petitions for exemption, please visit 

http://aes.faa.gov/petition/index.html. This website helps the petitioner to meet Federal 

Aviation Administration (FAA) requirement outlines in § 11.81 and helps answer any 

questions you may have.
2

What You Should Do

If you want us to process your request any further, you must submit the requested information 

within 30 days. Please note that § 11.63(d) requires you to send your petition for exemption 

at least 120 days before the proposed effective date of the exemption. 

If We Do Not Hear From You

If we do not receive the information, we will close the docket without notifying you further. 

If you have any questions you may call the 333 Information Line (202) 267-2999.

Sincerely,

/s/

Brittany Newton

Program Analyst, Airmen and

Airspace Rules Division

Enclosures
3
4
USDANEWS      VOLUME 57 NO.4 -May 1998
FY 2015 COPS Anti-Heroin Task Force Program Award List

State Agency Name Amount 

Awarded

ME Maine Drug Enforcement Agency at Augusta $389,160

MI Michigan Department of State Police $1,460,611 

NJ New Jersey Department of Law and Public Safety $103,227

TN Tennessee Bureau of Investigation $900,918 

VT Vermont State Police $1,430,519 

WI Wisconsin Department of Justice $1,499,992
#### §§ 217.158-217.159 [Reserved]
CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Apollo Medical Holdings, Inc. (the
“Company”) on Form 10-Q for the quarter ended April 30, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I, A.
Noel DeWinter, Chief Financial Officer and Principal Accounting Officer of the
Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act
of 2002, that:





(1)  The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities     Exchange Act of 1934; and




(2)  The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section  1350 and is not being filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and
is not to be incorporated by reference into any filing of the Company, whether
made before or after the date hereof, regardless of any general incorporation
language in such filing.








Dated:  November
      9, 2009
            By:
            /s/ A. NOEL
  DEWINTERNoel
      DeWinter
              Chief
      Financial Officer